{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:16:56Z","timestamp":1777634216037,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["98013096"],"award-info":[{"award-number":["98013096"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024506","name":"Tarbiat Modares University Faculty of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024506","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","award":["957970"],"award-info":[{"award-number":["957970"]}],"id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Immunology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cellimm.2026.105074","type":"journal-article","created":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T15:58:29Z","timestamp":1770739109000},"page":"105074","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Dendritic cells targeted CEA tumor antigen through DEC205 in combination with oncolytic reovirus stimulate strong immune response in colorectal cancer model"],"prefix":"10.1016","volume":"422","author":[{"given":"Nazila","family":"Hajiahmadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathias","family":"Tenbusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somayeh Shatizadeh","family":"Malekshahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atefeh","family":"Yari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Mohammad","family":"Moazzeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taravat","family":"Bamdad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cellimm.2026.105074_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellimm.2026.105074_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00866","article-title":"Oncolytic viral therapy and the immune system: a double-edged sword against cancer","volume":"9","author":"Marelli","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2026.105074_bb0015","series-title":"Colorectal cancer combination therapy using drug and gene co-delivered, targeted poly (ethylene glycol)-\u03b5-poly (caprolactone) nanocarriers","first-page":"3171","author":"Wang","year":"2018"},{"issue":"14","key":"10.1016\/j.cellimm.2026.105074_bb0020","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.3390\/ijms21145009","article-title":"Immunotherapies and combination strategies for immuno-oncology","volume":"21","author":"Barbari","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellimm.2026.105074_bb0025","series-title":"Kohrt HEJMct. Strategic combinations: the future of oncolytic virotherapy with reovirus","first-page":"767","volume":"15(5)","author":"Zhao","year":"2016"},{"key":"10.1016\/j.cellimm.2026.105074_bb0030","series-title":"Current understanding of reovirus oncolysis mechanisms. Oncolytic virotherapy","first-page":"53","author":"Phillips","year":"2018"},{"issue":"1","key":"10.1016\/j.cellimm.2026.105074_bb0035","doi-asserted-by":"crossref","first-page":"2200094","DOI":"10.1002\/gch2.202200094","article-title":"Combining of oncolytic virotherapy and other immunotherapeutic approaches in cancer: a powerful functionalization tactic","volume":"7","author":"Zou","year":"2023","journal-title":"Global Chall."},{"key":"10.1016\/j.cellimm.2026.105074_bb0040","first-page":"28","article-title":"Oncology. Cancer vaccines as promising immuno-therapeutics: platforms and current progress","volume":"15(1)","author":"Liu","year":"2022"},{"issue":"48","key":"10.1016\/j.cellimm.2026.105074_bb0045","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.3748\/wjg.v24.i48.5418","article-title":"Colorectal cancer vaccines: tumor-associated antigens vs neoantigens","volume":"24","author":"Wagner","year":"2018","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.cellimm.2026.105074_bb0050","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nri.2017.131","article-title":"Towards personalized, tumour-specific, therapeutic vaccines for cancer","volume":"18","author":"Hu","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.cellimm.2026.105074_bb0055","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/bjc.2012.605","article-title":"Carcinoembryonic antigen is the preferred biomarker for in vivo colorectal cancer targeting","volume":"108","author":"Tiernan","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.cellimm.2026.105074_bb0060","first-page":"1331","article-title":"A phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen","volume":"5","author":"Morse","year":"1999"},{"issue":"1","key":"10.1016\/j.cellimm.2026.105074_bb0065","first-page":"1","article-title":"A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment","volume":"23","author":"Liu","year":"2016"},{"issue":"5","key":"10.1016\/j.cellimm.2026.105074_bb0070","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.ymthe.2017.03.010","article-title":"Phase I escalating-dose trial of CAR-T therapy targeting CEA+ metastatic colorectal cancers","volume":"25","author":"Zhang","year":"2017","journal-title":"Mol. Ther."},{"issue":"1","key":"10.1016\/j.cellimm.2026.105074_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-23120-z","article-title":"Cancer vaccine therapy using carcinoembryonic antigen-expressing dendritic cells generated from induced pluripotent stem cells","volume":"8","author":"Kitadani","year":"2018","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cellimm.2026.105074_bb0080","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1080\/1750743X.2025.2501926","article-title":"Oncolytic reovirus enhances the effect of CEA immunotherapy when combined with PD1-PDL1 inhibitor in a colorectal cancer model","volume":"17","author":"Yari","year":"2025","journal-title":"Immunotherapy"},{"key":"10.1016\/j.cellimm.2026.105074_bb0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.trsl.2015.07.008","article-title":"Antitumor dendritic cell\u2013based vaccines: lessons from 20 years of clinical trials and future perspectives","volume":"168","author":"Constantino","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.cellimm.2026.105074_bb0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fimmu.2012.00013","article-title":"Targeting dendritic cells in vivo for cancer therapy","volume":"3","author":"Caminschi","year":"2012","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.cellimm.2026.105074_bb0095","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1147641","article-title":"A novel dendritic cell targeting HPV16 E7 synthetic vaccine in combination with PD-L1 blockade elicits therapeutic antitumor immunity in mice","volume":"5","author":"Liu","year":"2016","journal-title":"Oncoimmunology"},{"issue":"17","key":"10.1016\/j.cellimm.2026.105074_bb0100","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/j.vaccine.2020.02.034","article-title":"Therapeutic efficacy of PD1\/PDL1 blockade in B16 melanoma is greatly enhanced by immunization with dendritic cell-targeting lentiviral vector and protein vaccine","volume":"38","author":"Albershardt","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.cellimm.2026.105074_bb0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.intimp.2017.05.007","article-title":"Lenalidomide acts as an adjuvant for HCV DNA vaccine","volume":"48","author":"Borhani","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.cellimm.2026.105074_bb0110","series-title":"Hashempour TJIJoI. Low dose of lenalidomide enhances NK cell activity: possible implication as an adjuvant","first-page":"151","volume":"14(2)","author":"Borhani","year":"2017"},{"issue":"8","key":"10.1016\/j.cellimm.2026.105074_bb0115","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/CJI.0000000000000097","article-title":"Lenalidomide synergistically enhances the effect of dendritic cell vaccination in a model of murine multiple myeloma","volume":"38","author":"Nguyen-Pham","year":"2015","journal-title":"J. Immunother."},{"issue":"16","key":"10.1016\/j.cellimm.2026.105074_bb0120","doi-asserted-by":"crossref","first-page":"27252","DOI":"10.18632\/oncotarget.15917","article-title":"Combination therapy with dendritic cells and lenalidomide is an effective approach to enhance antitumor immunity in a mouse colon cancer model","volume":"8","author":"Vo","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.cellimm.2026.105074_bb0125","first-page":"215","article-title":"An endogenous immune adjuvant released by necrotic cells for enhancement of DNA vaccine potency","volume":"9","author":"Dorostkar","year":"2012","journal-title":"Iran. J. Immunol."},{"key":"10.1016\/j.cellimm.2026.105074_bb0130","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2020.1149","article-title":"Oncolytic virotherapy: new weapon for breast cancer treatment","volume":"14","author":"Martini","year":"2020","journal-title":"ecancermedicalscience"},{"key":"10.1016\/j.cellimm.2026.105074_bb0135","series-title":"Kinetics of oncolytic reovirus T3D replication and growth pattern in mesenchymal stem cells","first-page":"283","volume":"22(3)","author":"Banijamali","year":"2020"},{"key":"10.1016\/j.cellimm.2026.105074_bb0140","series-title":"Construction and characterization of recombinant adenovirus expressing single chain antibody against DEC205 receptor fused to carcino embryonic antigen for preliminary application in immunotherapy of cancer in mice","first-page":"15","volume":"(2)16","author":"Hajiahmadi","year":"2022"},{"issue":"4","key":"10.1016\/j.cellimm.2026.105074_bb0145","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/intimm\/dxs112","article-title":"Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response","volume":"25","author":"Tenbusch","year":"2013","journal-title":"Int. Immunol."},{"issue":"2","key":"10.1016\/j.cellimm.2026.105074_bb0150","doi-asserted-by":"crossref","first-page":"55","DOI":"10.52547\/vacres.8.2.55","article-title":"Establishment a carcinoembryonic antigen stable cell line for cancer immunotherapy study","volume":"8","author":"Bamdad","year":"2021","journal-title":"Vaccine Res."},{"issue":"12","key":"10.1016\/j.cellimm.2026.105074_bb0155","first-page":"5091","article-title":"Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients","volume":"30","author":"Lesterhuis","year":"2010"},{"key":"10.1016\/j.cellimm.2026.105074_bb0160","series-title":"Zhang YJHv, immunotherapeutics. Dendritic cell targeted vaccines: Recent progresses and challenges","first-page":"612","volume":"12(3)","author":"Chen","year":"2016"},{"issue":"8","key":"10.1016\/j.cellimm.2026.105074_bb0165","first-page":"1546","article-title":"How to differentiate pseudoprogression from true progression in cancer patients treated with immunotherapy","volume":"9","author":"Ma","year":"2019","journal-title":"Am. J. Cancer Res."},{"issue":"2","key":"10.1016\/j.cellimm.2026.105074_bb0170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1089\/hum.1997.8.2-187","article-title":"Carbone DPJHgt. Genetic immunotherapy of established tumors with adenovirus-murine granulocyte-macrophage colony-stimulating factor","volume":"8","author":"Lee","year":"1997","journal-title":"Hum. Gene Ther."},{"issue":"3","key":"10.1016\/j.cellimm.2026.105074_bb0175","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1006\/mthe.2000.0114","article-title":"Combination treatment of murine tumors by adenovirus-mediated local B7\/IL12 immunotherapy and radiotherapy","volume":"2","author":"Lohr","year":"2000","journal-title":"Mol. Ther."},{"issue":"5","key":"10.1016\/j.cellimm.2026.105074_bb0180","first-page":"809","article-title":"Immunotherapy for SV40 T\/t antigen-induced breast cancer by recombinant adeno-associated virus serotype 2 carrying interleukin-15 in mice","volume":"29","author":"Yiang","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cellimm.2026.105074_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.656908","article-title":"The role of tumor necrosis factor in manipulating the immunological response of tumor microenvironment","volume":"12","author":"Laha","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cellimm.2026.105074_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2023.102409","article-title":"Molecular mechanisms of tumour necrosis factor signalling via TNF receptor 1 and TNF receptor 2 in the tumour microenvironment","volume":"86","author":"Alim","year":"2024","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.cellimm.2026.105074_bb0195","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jnci\/djx123","article-title":"Comprehensive intrametastatic immune quantification and major impact of immunoscore on survival","volume":"110","author":"Mlecnik","year":"2018","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"8","key":"10.1016\/j.cellimm.2026.105074_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11081172","article-title":"The tumor microenvironment in colorectal cancer therapy","volume":"11","author":"Pedrosa","year":"2019","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.cellimm.2026.105074_bb0205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ddmec.2008.05.004","article-title":"Inheritance of colorectal cancer","volume":"4","author":"Burt","year":"2007","journal-title":"Drug Discov. Today Dis. Mech."}],"container-title":["Cellular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874926000146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008874926000146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:06:20Z","timestamp":1777439180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008874926000146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":41,"alternative-id":["S0008874926000146"],"URL":"https:\/\/doi.org\/10.1016\/j.cellimm.2026.105074","relation":{},"ISSN":["0008-8749"],"issn-type":[{"value":"0008-8749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dendritic cells targeted CEA tumor antigen through DEC205 in combination with oncolytic reovirus stimulate strong immune response in colorectal cancer model","name":"articletitle","label":"Article Title"},{"value":"Cellular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellimm.2026.105074","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105074"}}